Literature DB >> 16718854

Ultrasonic interventional analgesia in pancreatic carcinoma with chemical destruction of celiac ganglion.

Tao Wang1, Fu-Zhou Tian, Zhong-Hong Cai, Xu Li, Tao Cheng, Li Shi, Qi Cheng.   

Abstract

AIM: To detect the therapeutic effects of chemical destruction of celiac ganglion in patients with pancreatic carcinoma with intractable pain.
METHODS: Ninety-seven cases with advanced pancreatic carcinoma received chemical destruction of celiac ganglion-5 mL pure alcohol injection around celiac artery under ultrasonic guidance. The changes of visual analogue scale (VAS), serum substance P (Sub P), beta-endopeptide (beta-EP) and T-lymphocyte subtypes level were compared between pre- and post-therapy.
RESULTS: Successful rate of puncture was 98.7%, with one failure. No serious complications such as traumatic pancreatitis, pancreatic fistula, abdominal cavity hemorrhage or peritoneal infection occurred. VAS, serum Sub P and beta-EP level significantly changed after treatment (8.0+/-2.3 vs 4.6+/-2.1, 254.1+/-96.7 vs 182.4+/-77.6, 3.2+/-0.8 vs 8.8+/-2.1, P<0.01, P<0.05, P<0.01) with complete relief rate 54.2%, partial relief rate 21.9%, ineffective rate 12.5% and recurrent rate 10.7%. The T-lymphocyte subtypes level remarkably increased when compared with that of pre-therapy (46.7+/-3.7 vs 62.5+/-5.5, P<0.01).
CONCLUSION: Our study suggests that chemical destruction of celiac ganglion under ultrasonic guidance is highly safe, and can evidently relieve cancer pain and improve the cellular immunity in patients with advanced pancreatic carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718854      PMCID: PMC4087977          DOI: 10.3748/wjg.v12.i20.3288

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  10 in total

1.  Pain as a predictor of outcome in patients with operable pancreatic carcinoma.

Authors:  D P Kelsen; R Portenoy; H Thaler; Y Tao; M Brennan
Journal:  Surgery       Date:  1997-07       Impact factor: 3.982

2.  Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats.

Authors:  P J Cabot; L Carter; C Gaiddon; Q Zhang; M Schäfer; J P Loeffler; C Stein
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

3.  Intravenous phentolamine mesylate alleviates the pain of pancreatic carcinoma.

Authors:  Gary J McCleane
Journal:  Pain       Date:  1997-11       Impact factor: 6.961

Review 4.  Multiple opioid systems and pain.

Authors:  M J Millan
Journal:  Pain       Date:  1986-12       Impact factor: 6.961

5.  Opioid peptides modulate production of interferon gamma by human mononuclear cells.

Authors:  S L Brown; D E Van Epps
Journal:  Cell Immunol       Date:  1986-11       Impact factor: 4.868

6.  Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes.

Authors:  R J McDonough; J J Madden; A Falek; D A Shafer; M Pline; D Gordon; P Bokos; J C Kuehnle; J Mendelson
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

7.  beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.

Authors:  R N Mandler; W E Biddison; R Mandler; S A Serrate
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

8.  Morphine-induced thymic hypoplasia is glucocorticoid-dependent.

Authors:  Y Sei; K Yoshimoto; T McIntyre; P Skolnick; P K Arora
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

9.  Altered calcitonin gene-related peptide, substance P and enkephalin immunoreactivities and receptor binding sites in the dorsal spinal cord of the polyarthritic rat.

Authors:  S Kar; R G Rees; R Quirion
Journal:  Eur J Neurosci       Date:  1994-03-01       Impact factor: 3.386

10.  Morphine pellet-induced immunomodulation in mice: temporal relationships.

Authors:  H U Bryant; E W Bernton; J W Holaday
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

  10 in total
  3 in total

Review 1.  Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

Authors:  Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

Review 2.  Endoscopic ultrasonography guided celiac plexus neurolysis and celiac plexus block in the management of pain due to pancreatic cancer and chronic pancreatitis.

Authors:  Anthony J Michaels; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

3.  A New Perspective of Neuromyopathy to Explain Intractable Pancreatic Cancer Pains; Dry Needling as an Effective Adjunct to Neurolytic Blocks.

Authors:  Lakshmi Vas; Sushama Phanse; Renuka Pai
Journal:  Indian J Palliat Care       Date:  2016 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.